Objective Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly recognised for benefits beyond glycaemic ...

Please provide your email address to receive an email when new articles are posted on . Risks were particularly high in women who received both systemic and local hormone therapies. Future studies ...

Ed Gaudet is the CEO and Founder of Censinet, a healthcare risk management platform, and member of the Health Sector Coordinating Council. Merriam-Webster defines systemic risk as "the risk that the ...